APCCC 2019 PRESENTATION SLIDES

Get Free Access to Session Slides

APCCC 2019 VL

Looking Into the Future: Oligometastatic Disease Presentation - Misha Beltran

Details
During the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) Himisha Beltran presented an overview looking into the future of oligometastatic disease, and where she predicts we will be in two years’ time. Her presentation focused on refined clinical definitions for disease stratification, nominated molecular biomarkers to capture biologic disease states and defined goals of care for impro...

Prevention and Treatment of Osteoporosis Presentation - Fred Saad

Details
Fred Saad presented on bone and bone metastases at the Advanced Prostate Cancer Consensus Conference (APCCC) 2019 focusing on the prevention and treatment of osteoporosis. Given the relationship between ADT and bone loss, previous studies have established that ADT leads to increased fracture rates. Along with a proposed approached for men on ADT, Dr. Saad recommends the use of Fracture Risk Assess...

Local Treatment of the Primary Tumor (Surgery) in the Metastatic Setting Presentation - Thomas Steuber

Details
Thomas Steuber spoke on the role of surgery in the setting of metastatic prostate cancer at the Advanced Prostate Cancer Consensus Conference (APCCC 2019). He highlights the advantages of surgical removal of the primary tumor, the effects of surgery on cancer-specific survival and overall survival compared with no local treatment in the setting of de novo metastatic prostate cancer, and prospectiv...

Movember Session: Outcomes Research – IRONMAN Project - Alicia Morgans and Ian Davis

Details
Alicia Morgans and Ian Davis presented an update on the IRONMAN study, an International Registry for Men with Advanced Prostate Cancer at the Advanced Prostate Cancer Consensus Conference (APCCC). The ultimate goal of this project is to provide the most elaborate description and understanding of patients with advanced prostate cancer. The project includes a description of treatment changes, advers...

How to Treat Men with Newly Diagnosed cN1 cM0 Prostate Cancer: Surgery Options Presentation - Declan Murphy

Details
Declan Murphy presented on node-positive prostate cancer focusing on the staging of high-risk/locally advanced prostate cancer session on Node-positive Prostate Cancer (N1 but M0), How to Treat Men with Newly Diagnosed cN1 cM0 at the Advanced Prostate Cancer Consensus Conference (APCCC) 2019. He elaborates on the performance of conventional imaging for staging clinical node status and the evidence...

How to Treat Men With Newly Diagnosed cN1 cM0 Prostate Cancer - Systemic Therapy Options - Nicholas James

Details
Nick James presented on the systemic therapy options for men with node-positive hormone-sensitive prostate cancer (HSPC), including whether the primary tumor should be treated, and which treatments can be combined at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC). Also highlighted in his presentation is the role of docetaxel in M0 and M1 HSP, abiraterone’s role in high-risk M0 HSPC...

Management of Men With PSA Recurrence or Persistence After Prostatectomy: Presentation - Christopher Evans

Details
Christopher Evans, Professor and Chair, Department of Urologic Surgery at UC-Davis discussed the management of men with PSA recurrence or persistence after radical prostatectomy during the Advanced Prostate Cancer Consensus Conference (APCCC) 2019 session on PSA recurrence after radical local therapy and oligometastatic prostate cancer. He followed Dr. Felix Feng's presentation on PSA Recurrence a...

Management of Men with PSA Recurrence After Radical Local Radiation Therapy Presentation - Felix Feng

Details
Felix Feng presented during the PSA Recurrence after Radical Local Therapy and Oligometastatic Prostate Cancer session at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC). He focused on the topic of management of men with PSA recurrence after radical local radiation therapy. Of the 1.2 million-plus patients that are diagnosed with prostate cancer each year worldwide, in the United St...

Disparities in Prostate Cancer Management in the United States Presentation - Alicia Morgans

Details
At the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) Dr. Alicia Morgans presented on disparities in prostate cancer management in the United States. Dr. Morgans highlights the 174,650 new cases of prostate cancer in the United States in 2019 and noting that social health is determined by many factors which could be responsible for these disparities, she frames her discussion around wh...

Report and Lessons Learned From The Consensus Conference For Developing Countries Presentation - Fernando Maluf

Details
In this presentation by Fernando Maluf at the 2019 Advanced Prostate Cancer Consensus Conference (APCCC) he summarizes the results of the first Latin American Oncology Group (LACOG) consensus conference, a Cooperative Group Consensus that takes place in Brazil, a consensus conference for developing countries. This unique conference provided guidelines for prostate cancer, specifically for areas of...